Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.

[1]  M. Overgaard.  Spontaneous radiation-induced rib fractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of the influence of fraction size and dose-response relationships on late bone damage. , 1988, Acta oncologica.

[2]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[3]  Stereotactic Body Radiation Therapy of Lung Tumors: Preliminary Experience Using Normal Tissue Complication Probability-Based Dose Limits , 2005, American journal of clinical oncology.

[4]  S M Bentzen,et al.  Quantifying the position and steepness of radiation dose-response curves. , 1997, International journal of radiation biology.

[5]  J. Wong,et al.  On methods of inhomogeneity corrections for photon transport. , 1990, Medical physics.

[6]  H Meertens,et al.  Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. , 2001, International journal of radiation oncology, biology, physics.

[7]  Luca Cozzi,et al.  On the dosimetric behaviour of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations , 2007, Physics in medicine and biology.

[8]  S. Rosfors,et al.  ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer. , 2006, International journal of radiation oncology, biology, physics.

[9]  Jeffrey Bradley,et al.  Radiographic Response and Clinical Toxicity Following SBRT for Stage I Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  W. Schlegel,et al.  Prediction of radiation-induced changes in the lung after stereotactic body radiation therapy of non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.

[11]  R. Mohan,et al.  Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[12]  K. Johansson,et al.  Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients. , 2006, Lung cancer.

[13]  Masahiro Hiraoka,et al.  Current status of stereotactic body radiotherapy for lung cancer , 2007, International Journal of Clinical Oncology.

[14]  Hiroki Shirato,et al.  STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .

[15]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[16]  D. Schultz,et al.  The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. , 1996, International journal of radiation oncology, biology, physics.

[17]  Joe Y. Chang,et al.  Stereotactic body radiation therapy for stage I non-small cell lung cancer. , 2007, Thoracic surgery clinics.

[18]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[19]  S. Tung,et al.  Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Luca Cozzi,et al.  Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations , 2006, Physics in medicine and biology.

[21]  Michael Flentje,et al.  Stereotactic Radiotherapy of Targets in the Lung and Liver , 2001, Strahlentherapie und Onkologie.

[22]  G J Kutcher,et al.  Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. , 1995, International journal of radiation oncology, biology, physics.

[23]  M. Goitein,et al.  Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.

[24]  F. Vicini,et al.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[25]  In Reply to Dr. Fowler and Dr. Kavanagh , 2008 .

[26]  N. Hayabuchi,et al.  [Rib fracture after postoperative tangential irradiation in breast cancer]. , 1987, Gan no rinsho. Japan journal of cancer clinics.

[27]  Branislav Jeremic,et al.  Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. , 2005, Lung cancer.

[28]  I. Turesson.  Characteristics of dose-response relationships for late radiation effects: an analysis of skin telangiectasia and of head and neck morbidity. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  A Brahme,et al.  Dosimetric precision requirements in radiation therapy. , 1984, Acta radiologica. Oncology.

[30]  S. Singletary,et al.  Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. , 2000, International journal of radiation oncology, biology, physics.

[31]  P. Stavrev,et al.  Derivation of the expressions for gamma50 and D50 for different individual TCP and NTCP models. , 2002, Physics in medicine and biology.

[32]  Robert D Timmerman,et al.  The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[33]  Xiao-dong Zhu,et al.  Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. , 2006, International journal of radiation oncology, biology, physics.

[34]  Y. Pawitan.  In all likelihood : statistical modelling and inference using likelihood , 2002 .

[35]  R. T. Ten Haken,et al.  Partial volume tolerance of the liver to radiation. , 2005, Seminars in radiation oncology.

[36]  H. Withers,et al.  Biologic basis of radiation therapy , 1987 .

[37]  M. Astrahan,et al.  Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation. , 2008, Medical physics.

[38]  S. Bentzen.  Steepness of the radiation dose-response curve for dose-per-fraction escalation keeping the number of fractions fixed , 2005, Acta oncologica.

[39]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[40]  P. Storchi,et al.  Calculation of the absorbed dose distribution due to irregularly shaped photon beams using pencil beam kernels derived form basic beam data. , 1996, Physics in medicine and biology.

[41]  J. Fowler.  Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852). , 2008, International journal of radiation oncology, biology, physics.

[42]  I. Lax,et al.  Dose distributions in SBRT of lung tumors: Comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions , 2006, Acta oncologica.